Published in Medical Letter on the CDC and FDA, April 20th, 2003
The trial, named "Bone 97, A Dietary Strategy to Maximize Bone Mass in U.S. Naval Academy Mid-Shipmen," was funded by the Department of the Army. The principal investigator is an FDA employee, and the coprincipal investigator is employed by a private foundation.
FDA is requesting this investigation because of apparent lapses that occurred during the conduct of this study and failure to safeguard information collected as part of this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.